Company profile
NewCardio, Inc.
OTC: NWCI · Healthcare · Medical - Devices
PublicHQ Branchburg, NJReports USD
#983 of 1,418 Healthcare companies by revenue
EA Score
——FH —DQ —GM —SS 36
v0.1 · 5/100 weight · pillars only
↑ listing tenure, disclosure history · ↓ Altman-Z, market scale
Methodology →Revenue TTM
$238.6k
Rev growth YoY (TTM)
+40.9%
Net income (FY)
-$11.5M
Employees
10
as of 2026-08-30
Market cap
$3.3k
as of 2026-08-30
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$257.4k$257.4k2010
Net income-$11.5M-$11.5M2010
Operating income-$9.5M-$9.5M2010
Total assets$2.9M$2.9M2010
Liabilities$6.0M$6.0M2010
Equity-$3.2M-$3.2M2010
Revenue trend
FY2004 – FY2010 · USD
FY04
FY05
FY06
FY07
FY08
FY09
FY10
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is NewCardio, Inc.’s revenue?
NewCardio, Inc. booked $257.4k in FY2010 revenue — among the slowest-growing Healthcare companies we track, at a -4466.2% net margin.
Peers · Healthcare
Entia Biosciences, Inc.——CEL-SCI Corporation32DNutra Pharma Corp.30DSavara Inc.50DNexteligent Holdings, Inc.46DAdhera Therapeutics Inc——Key facts
CEOJess Emery Jones
SectorHealthcare
IndustryMedical - Devices
HeadquartersBranchburg, NJ
ExchangeOTC: NWCI
Employees10
IPO date2008-01-04
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.